LANGUAGE
KOREAN
ENGLISH
LOCATION
COMPANY
R&D
R&D Institute
GMP Center
Clinical Development Status
Publications
PRODUCTS
1st Generation
Overview
CARTISTEM
®
PNEUMOSTEM
®
2nd Generation
Overview
SMUP-IA-01
SMUP-IV-01
R&D Inquiries
BUSINESS
CDMO
Quality System
CDMO Service
Quality Control
Global CDMO
CDMO Inquiries
CELLTREE Cord Blood Bank
MOVITA Nutritional Supplements
IR
Stock Information
Disclosure
Financial Information
IR Inquiries
PR
MEDIPOST on Media
Corporate Brochure
CONTACT US
Customer Center
R&D Inquiries
CDMO Inquiries
IR Inquiries
Stock Info
Disclosure
Financial Information
IR Inquiries
Disclosure
2024-11-21 08:51:29
No.
Date
Disclosure Contents
10
2024.10.18
Material Management Information related to Judgment of Investment(Study Results)(미숙아 중증 기관지폐이형성증(Bronchopulmonary Dysplasia, 이하 BPD)에 대한 뉴모스템®의 국내 임상 2상 시험 결과)
9
2024.06.28
Other Market Information(업종변경 안내)
8
2024.05.10
Material Management Information related to Judgment of Investment(Study Results)(무릎 골관절염 환자를 대상으로 SMUP-IA-01의 국내 임상2상 임상시험 결과)
7
2024.04.23
Decision on Acquisition of Shares or Investment Securities of Other Corporation
6
2024.04.23
Decision on Acquisition of Shares or Investment Securities of Other Corporation
5
2024.04.23
Decision on Paid-in Capital Increase(Material Management Matters of Subsidiary Company)
4
2024.03.28
Outcomes of Annual Meeting of Shareholders
3
2024.03.20
Submission of Audit Report
2
2024.03.12
Resolutions for Convocation of General Meeting of Shareholders
1
2024.02.14
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
Stock Info
Disclosure
Financial Information
IR Inquiries
Menu